📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

The synthetic TRPML1 agonist, ML-SA1, rescues Alzheimer-related alterations of the endosomal-autophagic-lysosomal system

First Author: Somogyi, A

Attributed to: Therapeutic targeting of impaired lysosomal flux in Alzheimer's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Journal Article/Review

Parent Publication: Journal of Cell Science